
Sign up to save your podcasts
Or


Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
By American Academy of Neurology4.8
132132 ratings
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561

328 Listeners

501 Listeners

303 Listeners

54 Listeners

297 Listeners

3,384 Listeners

13 Listeners

1,153 Listeners

27 Listeners

197 Listeners

90 Listeners

518 Listeners

362 Listeners

187 Listeners

82 Listeners